KC
Kenfarb & Co Portfolio holdings
AUM
$109M
This Quarter Return
-2.66%
1 Year Return
+18%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$109M
AUM Growth
+$109M
(-4.7%)
Cap. Flow
-$1.36M
Cap. Flow
% of AUM
-1.25%
Top 10 Holdings %
Top 10 Hldgs %
32.99%
Holding
216
New
2
Increased
4
Reduced
43
Closed
3
Top Buys
| 1 |
Verizon
VZ
|
$264K |
| 2 |
Enbridge
ENB
|
$122K |
| 3 |
Novo Nordisk
NVO
|
$114K |
| 4 |
Kenvue
KVUE
|
$49.6K |
| 5 |
MetLife
MET
|
$6.29K |
Top Sells
| 1 |
Microsoft
MSFT
|
$224K |
| 2 |
Eli Lilly
LLY
|
$220K |
| 3 |
Mastercard
MA
|
$198K |
| 4 |
Invesco QQQ Trust
QQQ
|
$129K |
| 5 |
Abbott
ABT
|
$104K |
Sector Composition
| 1 | Technology | 28.44% |
| 2 | Healthcare | 16.32% |
| 3 | Industrials | 11.42% |
| 4 | Consumer Staples | 7% |
| 5 | Utilities | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
CSX Corp
CSX
$60.6B
| $653K | 0.6% |
21,250
| – | – |
|
52
Xcel Energy
XEL
$42.8B
| $641K | 0.59% |
11,195
-150
| -1% | -$8.58K |
|
53
Vodafone
VOD
$28.8B
| $599K | 0.55% |
63,200
| – | – |
|
|
54
Invesco QQQ Trust
QQQ
$364B
| $573K | 0.52% |
1,599
-360
| -18% | -$129K |
|
55
Mettler-Toledo International
MTD
$26.8B
| $561K | 0.51% |
506
| – | – |
|
56
Amazon
AMZN
$2.44T
| $559K | 0.51% |
4,400
| – | – |
|
57
CDW
CDW
$21.6B
| $557K | 0.51% |
2,760
| – | – |
|
58
Visa
V
$683B
| $531K | 0.49% |
2,308
| – | – |
|
59
Procter & Gamble
PG
$368B
| $527K | 0.48% |
3,613
| – | – |
|
60
JPMorgan Chase
JPM
$829B
| $517K | 0.47% |
3,562
| – | – |
|
61
McCormick & Company Non-Voting
MKC
$18.9B
| $511K | 0.47% |
6,763
| – | – |
|
62
Utilities Select Sector SPDR Fund
XLU
$20.9B
| $504K | 0.46% |
8,545
-200
| -2% | -$11.8K |
|
63
Atmos Energy
ATO
$26.7B
| $478K | 0.44% |
4,516
-100
| -2% | -$10.6K |
|
64
Zoetis
ZTS
$69.3B
| $471K | 0.43% |
2,705
| – | – |
|
65
Watsco
WSO
$16.3B
| $463K | 0.42% |
1,225
| – | – |
|
66
Bank of America
BAC
$376B
| $438K | 0.4% |
16,000
| – | – |
|
67
Rollins
ROL
$27.4B
| $435K | 0.4% |
11,650
| – | – |
|
68
Novartis
NVS
$245B
| $428K | 0.39% |
4,200
| – | – |
|
69
Enterprise Products Partners
EPD
$69.6B
| $421K | 0.39% |
15,400
| – | – |
|
70
Pfizer
PFE
$141B
| $388K | 0.35% |
11,700
| – | – |
|
71
Unilever
UL
$155B
| $385K | 0.35% |
7,800
| – | – |
|
72
PureCycle Technologies
PCT
$2.57B
| $373K | 0.34% |
66,456
| – | – |
|
73
Boeing
BA
$177B
| $364K | 0.33% |
1,900
| – | – |
|
74
Johnson & Johnson
JNJ
$427B
| $356K | 0.33% |
2,287
-308
| -12% | -$48K |
|
75
S&P Global
SPGI
$167B
| $352K | 0.32% |
964
-30
| -3% | -$11K |
|